Navigation Links
Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices
Date:5/20/2013

ALISO VIEJO, Calif., May 20, 2013 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has received CE mark for the SL ("Single Layer") family of WEB® Aneurysm Embolization Devices, and has commenced a controlled release of these new models in select neurovascular centers in Europe.  The SL family offers a lower profile and superior navigability that will enable physicians to treat a broader range of aneurysms with the WEB platform.

The SL configurations are made possible by further advancement of Sequent Medical's proprietary MicroBraid™ technology, a dense mesh constructed from a large number of extremely fine Nitinol wires.  Unlike conventional medical braids, MicroBraid features a mix of wire diameters and high wire counts to achieve a tailored balance of compliance, porosity and profile across device sizes. 

The SL family consists of two separate product configurations, the WEB SL and WEB SLS, each with a distinct shape designed to accommodate varying aneurysm morphologies.  Both configurations are available in multiple sizes ranging from 4-11 mm and are designed for delivery through Sequent Medical's VIA microcatheters.

The WEB SL and WEB SLS will build upon the growing experience with the original dual layer WEB, now referred to as the WEB DL configuration, which has now been used to treat over 280 ruptured and unruptured aneurysms in Europe and Latin America. 

"Sequent Medical has responded to physicians' requests in developing the WEB SL configurations," said Prof Laurent Pierot , MD PhD, Head of the Department of Radiology, Maison Blanche Hospital, Reims, France.  "The SL family promises to expand the range of aneurysms physicians can treat with the WEB while continuing to offer the familiar straightforward procedure we've come to value with the WEB DL." 

"Combined with our recently introduced VIA microcatheter line, the introduction of the SL products demonstrates Sequent Medical's ongoing commitment to developing a broad portfolio of innovative catheter-based technologies for neurovascular specialists and their patients," said Tom Wilder , President and Chief Executive Officer. 

About Sequent Medical, Inc.

Founded in 2007, Sequent Medical, Inc. (www.sequentmedical.com) is a privately held venture backed medical-device company that is dedicated to the development of innovative catheter-based neurovascular technologies.  The WEB Aneurysm Embolization System and VIA Microcatheter have both received the CE mark.  They are not approved for or available for sale or use in the United States.  Sequent Medical, Inc. is headquartered in Aliso Viejo, California, and has European operations based in Bonn, Germany.

About The WEB Aneurysm Embolization System

Building upon the foundation of endovascular embolic coils, the WEB is a low porosity intrasaccular neurovascular embolization device that is designed to bridge the neck of a ruptured or unruptured intracranial aneurysm and to promote rapid, peri-procedural stasis. The WEB enables physicians to treat a broad range of intracranial aneurysms with the familiarity of an intrasaccular approach while using established biomaterials.  The WEB product portfolio consists of the original WEB DL configuration and the recently introduced WEB SL and WEB SLS offerings.    


'/>"/>
SOURCE Sequent Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt
2. Researchers Funded By The Pancreatic Cancer Action Network Leverage $9.15 Million Investment By The Organization Into $91 Million In Subsequent Pancreatic Cancer Research Funding
3. Sequent Medical, Inc. führt VIA-Mikrokatheter ein
4. Sequent Medical, Inc. lance le microcathéter VIA
5. Sequent Medical, Inc. lanza el microcatéter VIA
6. Sequent Medical, Inc. Launches VIA Microcatheter
7. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
8. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
9. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
10. Parametrics Medical, LLC Announces the Release of Their Coll-e-Strong Line of Soft Tissue Allografts
11. Haemonetics Completes Hemerus Medical, LLC Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/9/2019)... ISLAND, N.Y. (PRWEB) , ... August 09, 2019 ... ... today announced their Lynbrook location, currently at 360 Merrick Road, will be moving ... 3rd, 2019. , The new Oceanside office offers additional features and technologies to ...
(Date:8/9/2019)... , ... August 09, 2019 , ... ... annual conference in its 15-year history, themed “The Foundation of Health Care,” at ... CM-granting conference will feature a variety of prestigious keynote presenters, including Lifestyle Medicine ...
(Date:8/9/2019)... ... August 08, 2019 , ... Isagenix International , ... its second round of Canada finalists for its annual total-body transformation program, the ... Selwyn, Ontario; Dwight Hodel of Medicine Hat, Alberta; Jennifer Bounds of Fort McMurray, ...
Breaking Medicine Technology:
(Date:8/17/2019)... ... August 17, 2019 , ... ... America’s Fastest-Growing Private Companies—the Inc. 5000 , For the 2nd Year In a ... Revenue Growth of 192% Percent , Inc. magazine today revealed that YellowTelescope LLC ...
(Date:8/16/2019)... ... August 16, 2019 , ... The employees ... children’s aircraft to Ronald McDonald House Charities in New Hyde Park, Long Island, ... medical treatments and their family members a comfortable and fun way to watch ...
(Date:8/15/2019)... ... August 15, 2019 , ... ... pathology residents who have been directly affected by the closure of Hahnemann University ... donations gathered during the campaign, the ASCP Foundation will be making hardship grants ...
(Date:8/14/2019)... (PRWEB) , ... August 14, 2019 , ... Teguar Corporation ... companies in America. This list has long-been established as a mark of success for ... LinkedIn, Dell, and Oracle. Teguar made the list in 2015, 2016 and 2017. This ...
(Date:8/14/2019)... N.H. (PRWEB) , ... August 13, 2019 , ... New ... the heart-healthy antioxidant resveratrol, today announced an expansion of its line of CBD-infused coffees ... 300 mg of CBD in a 12-oz bag. , “We are excited to ...
Breaking Medicine News(10 mins):